Liberum appointed as Joint Corporate Broker to UDG Healthcare
We are pleased to announce that Liberum has been appointed as Joint Broker to UDG Healthcare plc.
UDG, a leading international healthcare services provider, has a premium listing in London and is a FTSE 250 constituent, with a market capitalisation of £1.9 billion.
UDG delivers advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 9,000 people with operations in 26 countries and delivering services in over 50 countries, through its two divisions: Ashfield and Sharp.
Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.
Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.
Liberum Team
Investment Banking – John Fishley, Bidhi Bhoma, Euan Brown, Kane Collings
Research – Graham Doyle, Alistair Campbell
Sales – Seb Fernandez
US – Richard Kramer, Holly Whelan
CIR – Rosa Hibbert-Keene
